Procalcitonin testing for diagnosis and short-term prognosis in bacterial infection complicated by congestive heart failure: A multicenter analysis of 4,698 cases

Critical Care

Volumn 18, Issue 1, 2014, Pages

  Wang, Weijia ^a   Zhang, Xiuming ^a   Ge, Na ^b   Liu, Jing ^a   Yuan, Huimin ^c   Zhang, Peng ^d   Liu, Wei ^e   Wen, Dongmei ^a  

^a SUN YAT SEN UNIVERSITY   (China)

^b INNER MONGOLIA UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^c CAPITAL MEDICAL UNIVERSITY   (China)

^d FIRST MILITARY MEDICAL UNIVERSITY   (China)

^e UNION HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; INTERLEUKIN 6; PROCALCITONIN; BIOLOGICAL MARKER; CALCITONIN; PROTEIN PRECURSOR;

ADULT; AGED; ARTICLE; BACTERIAL INFECTION; CHEMILUMINESCENCE ANALYZER; CHEMILUMINESCENCE IMMUNOASSAY; CHINA; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; FEMALE; HEART FUNCTION; HUMAN; IMMUNOASSAY ANALYZER; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MULTICENTER STUDY; PREDICTIVE VALUE; PRIORITY JOURNAL; PROGNOSIS; RECEIVER OPERATING CHARACTERISTIC; SCREENING; SENSITIVITY AND SPECIFICITY; SURVIVAL; YOUNG ADULT; BACTERIAL INFECTIONS; BLOOD; CLINICAL TRIAL; HEART FAILURE;

ADULT; AGED; BACTERIAL INFECTIONS; BIOLOGICAL MARKERS; CALCITONIN; CHINA; FEMALE; HEART FAILURE; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; PROTEIN PRECURSORS;

EID: 84891498096     PISSN: 13648535     EISSN: 1466609X     Source Type: Journal    
DOI: 10.1186/cc13181     Document Type: Article

References (23)

1. Giamarellos-Bourboulis EJ, Mega A, Grecka P, Scarpa N, Koratzanis G, Thomopoulos G, Giamarellou H. Procalcitonin: a marker to clearly differentiate systemic inflammatory response syndrome and sepsis in the critically ill patient?. Intensive Care Med 2002, 28:1351-1356. 10.1007/s00134-002-1398-z, 12209289.
2. Müller B, Harbarth S, Stolz D, Bingisser R, Mueller C, Leuppi J, Nusbaumer C, Tamm M, Christ-Crain M. Diagnostic and prognostic accuracy of clinical and laboratory parameters in community-acquired pneumonia. BMC Infect Dis 2007, 7:10. 10.1186/1471-2334-7-10, 1821031, 17335562.
3. Meisner M, Adina H, Schmidt J. Correlation of procalcitonin and C-reactive protein to inflammation, complications, and outcome during the intensive care unit course of multiple-trauma patients. Crit Care 2006, 10:R1. 10.1186/cc3910, 1550798, 16356205.
4. Schwarz S, Bertram M, Schwab S, Andrassy K, Hacke W. Serum procalcitonin levels in bacterial and abacterial meningitis. Crit Care Med 2000, 28:1828-1832. 10.1097/00003246-200006000-00024, 10890628.
5. Assicot M, Gendrel D, Carsin H, Raymond J, Giulbaud J, Bohuon C. High serum procalcitonin concentrations in patients with sepsis and infection. Lancet 1993, 341:515-518. 10.1016/0140-6736(93)90277-N, 8094770.
6. Müller B, Becker KL, Schächinger H, Richenbacker PR, Huber PR, Zimmerli W, Ritz R. Calcitonin precursors are reliable markers of sepsis in a medical intensive care unit. Crit Care Med 2000, 28:977-983. 10.1097/00003246-200004000-00011, 10809269.
7. Gendrel D, Raymond J, Assicot M, Avenel S, Lefèvre H, Ravilly S, Moulin F, Lacombe C, Palmer P, Lebon P, Bohuon C. [Procalcitonin, C-reactive protein and interleukin 6 in bacterial and viral meningitis in children] [in French]. Presse Med 1998, 27:1135-1139.
8. Moosig F, Csernok E, Reinhold-Keller E, Schmitt W, Gross WL. Elevated procalcitonin levels in active Wegener's granulomatosis. J Rheumatol 1998, 25:1531-1533.
9. Dandona P, Nix D, Wilson MF, Aljada A, Love J, Assicot M, Bohuon C. Procalcitonin increase after endotoxin injection in normal subjects. J Clin Endocrinol Metab 1994, 79:1605-1608.
10. Christ-Crain M, Jaccard-Stolz D, Bingisser R, Gencay MM, Huber PR, Tamm M, Müller B. Effect of procalcitonin-guided treatment on antibiotic use and outcome in lower respiratory tract infections: cluster-randomised, single-blinded intervention trial. Lancet 2004, 363:600-607. 10.1016/S0140-6736(04)15591-8, 14987884.
11. Bouadma L, Luyt CE, Tubach F, Cracco C, Alvarez A, Schwebel C, Schortgen F, Lasocki S, Veber B, Dehoux M, Bernard M, Pasquet B, Régnier B, Brun-Buisson C, Chastre J, Wolff M, PRORATA trial group Use of procalcitonin to reduce patients' exposure to antibiotics in intensive care units (PRORATA trial): a multicentre randomised controlled trial. Lancet 2010, 375:463-474. 10.1016/S0140-6736(09)61879-1, 20097417, PRORATA trial group.
12. Schuetz P, Albrich W, Mueller B. Procalcitonin for diagnosis of infection and guide to antibiotic decisions: past, present and future. BMC Med 2011, 9:107-116. 10.1186/1741-7015-9-107, 3186747, 21936959.
13. Sandek A, Springer J, Habedank D, Brunkhorst F, Anker SD. Procalcitonin-guided antibiotic treatment in heart failure [Letter]. Lancet 2004, 363:1555-1556.
14. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D, Modification of Diet in Renal Disease Study Group A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Ann Intern Med 1999, 130:461-470. 10.7326/0003-4819-130-6-199903160-00002, 10075613, Modification of Diet in Renal Disease Study Group.
15. Elenius V, Peltola V, Ruuskanen O, Ylihärsilä M, Waris M. Plasma procalcitonin levels in children with adenovirus infection [Letter]. Arch Dis Child 2012, 97:582-583.
16. Meisner M, Lohs T, Huettemann E, Schmidt J, Hueller M, Reinhart K. The plasma elimination rate and urinary secretion of procalcitonin in patients with normal and impaired renal function. Eur J Anaesthesiol 2001, 18:79-87.
17. Zhang X, Wang W, Yu Y, Wang Q, Yang Y, Wen D, Li F, Ouyang N, Kan L, Suo M, Yan H. BNP and NT-proBNP assays for heart-failure diagnosis in patients with cerebral infarction. Lab Med 2013, 44:46-50.
18. Bottner F, Wegner A, Winkelmann W, Becker K, Erren M, Götze C. Interleukin-6, procalcitonin and TNF-α: markers of peri-prosthetic infection following total joint replacement. J Bone Joint Surg Br 2007, 89:94-99.
19. Brodská H, Malíčková K, Adámková V, Benáková H, Šťastná MM, Zima T. Significantly higher procalcitonin levels could differentiate Gram-negative sepsis from Gram-positive and fungal sepsis. Clin Exp Med 2013, 13:165-170. 10.1007/s10238-012-0191-8, 22644264.
20. Eto D, Lao C, DiToro D, Barnett B, Escobar TC, Kageyama R, Yusuf I, Crotty S. IL-21 and IL-6 are critical for different aspects of B cell immunity and redundantly induce optimal follicular helper CD4 T cell (Tfh) differentiation. PLoS One 2011, 6:e17739. 10.1371/journal.pone.0017739, 3056724, 21423809.
21. Agarwal S, Piesco NP, Johns LP, Riccelli AE. Differential expression of IL-1β, TNF-α, IL-6, and IL-8 in human monocytes in response to lipopolysaccharides from different microbes. J Dent Res 1995, 74:1057-1065. 10.1177/00220345950740040501, 7782536.
22. Drees M, Kanapathippilai N, Zubrow MT. Bandemia with normal white blood cell counts associated with infection. Am J Med 2012, 125:1124.e9-1124.e15.
23. Almansa R, Socias L, Andaluz-Ojeda D, Martín-Loeches I, Bobillo F, Blanco J, Rico L, Berezo J, Estella T, Sanchez-Garcia M, San José A, Herrero A, Justel M, Roig V, Del Olmo M, Rosich S, Rodriguez I, Disdier C, Eiros JM, Ortiz De Lejarazu R, Bermejo-Martin JF. Viral infection is associated with an increased proinflammatory response in chronic obstructive pulmonary disease. Viral Immunol 2012, 25:249-253. 10.1089/vim.2011.0095, 22746693.